CARE SOLUTIONS ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Bankruptcy risk for industry  3.3% 3.3% 3.3% 3.3% 3.3%  
Bankruptcy risk  2.7% 2.1% 2.2% 3.3% 10.6%  
Credit score (0-100)  62 67 65 54 22  
Credit rating  BBB BBB BBB BBB BB  
Credit limit (kDKK)  0.0 0.1 0.1 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4

Net sales  0 0 0 0 0  
Gross profit  454 735 317 151 -202  
EBITDA  454 735 317 119 -578  
EBIT  438 729 308 110 -587  
Pre-tax profit (PTP)  436.7 725.6 297.8 106.9 -587.1  
Net earnings  340.6 565.9 230.7 83.4 -457.9  
Pre-tax profit without non-rec. items  437 726 298 107 -587  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4

Tangible assets total  23.3 17.1 23.5 13.9 4.4  
Shareholders equity total  341 907 1,138 1,222 764  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  818 1,317 1,240 1,339 906  

Net Debt  -250 -747 -731 -1,019 -447  
 
See the entire balance sheet

Volume 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  454 735 317 151 -202  
Gross profit growth  44.5% 62.0% -56.9% -52.4% 0.0%  
Employees  0 0 0 0 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  818 1,317 1,240 1,339 906  
Balance sheet change%  -47.4% 61.1% -5.9% 8.0% -32.4%  
Added value  453.9 735.4 316.8 118.6 -577.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -4 -13 -3 -19 -19  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 -1.0  

Profitability 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  96.5% 99.1% 97.2% 72.8% 290.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  36.9% 68.3% 24.1% 8.5% -52.3%  
ROI %  52.9% 116.9% 30.1% 9.3% -59.1%  
ROE %  36.0% 90.7% 22.6% 7.1% -46.1%  

Solidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Equity ratio %  41.6% 68.8% 91.8% 91.9% 90.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -55.2% -101.6% -230.6% -854.2% 77.3%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.2% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Quick Ratio  1.2 2.7 9.9 10.4 8.6  
Current Ratio  1.2 2.7 10.0 9.6 4.9  
Cash and cash equivalent  250.5 747.2 730.5 1,018.5 446.8  

Capital use efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  117.3 689.7 914.7 1,007.7 559.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 -578  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 -578  
EBIT / employee  0 0 0 0 -587  
Net earnings / employee  0 0 0 0 -458